Home › Epilepsy › Washington
Epilepsy clinical trials in Washington
3 studies for Epilepsy are looking for participants at sites in Washington.
Cities in Washington
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- University of Washington, Regional Epilepsy Center at Harborview Medical Center, Seattle
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT05667142Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Washington Regional Epilepsy Center, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Seattle Children's Hospital, Seattle
RecruitingPhase 2
1 Day – 6 Months · All sexes · Updated Jan 22, 2026 · NCT05104983From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.